Cargando…
Corrigendum to: Prospective evaluation of high‐dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney function
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010260/ https://www.ncbi.nlm.nih.gov/pubmed/35235254 http://dx.doi.org/10.1111/cts.13234 |
| _version_ | 1784687446958538752 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9010260 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90102602022-04-18 Corrigendum to: Prospective evaluation of high‐dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney function Clin Transl Sci Corrigenda John Wiley and Sons Inc. 2022-03-02 2022-04 /pmc/articles/PMC9010260/ /pubmed/35235254 http://dx.doi.org/10.1111/cts.13234 Text en © 2022 The Authors. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of the American Society for Clinical Pharmacology and Therapeutics. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Corrigenda Corrigendum to: Prospective evaluation of high‐dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney function |
| title | Corrigendum to: Prospective evaluation of high‐dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney function |
| title_full | Corrigendum to: Prospective evaluation of high‐dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney function |
| title_fullStr | Corrigendum to: Prospective evaluation of high‐dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney function |
| title_full_unstemmed | Corrigendum to: Prospective evaluation of high‐dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney function |
| title_short | Corrigendum to: Prospective evaluation of high‐dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney function |
| title_sort | corrigendum to: prospective evaluation of high‐dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney function |
| topic | Corrigenda |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010260/ https://www.ncbi.nlm.nih.gov/pubmed/35235254 http://dx.doi.org/10.1111/cts.13234 |